Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
Regulatory affairs, pharmacovigilance and compliance services for life sciences
ProductLife Group is a life sciences consulting and outsourcing company providing regulatory affairs, pharmacovigilance and quality services to pharmaceutical, biotechnology and medical technology organisations. Its teams prepare regulatory submissions, manage product registrations, monitor medicine safety and support…
2D barcoded sample storage tubes and automated handling equipment
AltemisLab is a Cambridge-based manufacturer of 2D barcoded sample storage tubes, barcode readers, and automated capping and decapping equipment for laboratory sample management. Its range covers multiple storage formats including 96 SBS racks designed for short and long-term cryogenic storage. Complementary hardware…
Small molecule therapeutics targeting astrocytes in Parkinson's disease
Cellestial Health is a pre-clinical stage biotechnology company and University of Cambridge spinout developing small molecule therapeutics for Parkinson's disease and other neurodegenerative conditions. The company's approach targets astrocytic networks, a class of brain cells whose dysregulation contributes to…
Plasmonic PCR diagnostics for rapid infectious disease detection
RapidX Bio is a biotechnology company developing point-of-care molecular diagnostics for infectious diseases. Its plasmonic PCR technology uses light-responsive gold nanorods to accelerate nucleic acid amplification and reduce sample preparation requirements. The company is developing portable tests to identify…
Cambridge R&D hub for GPCR-based drug discovery
Nxera Pharma UK is the Cambridge-based drug discovery arm of Tokyo-listed Nxera Pharma, formerly Sosei Heptares, operating from Granta Park with approximately 170 scientists. Its structure-based drug discovery capabilities have produced over 50 resolved GPCR structures. Following a restructuring in November 2025, the…
Biomimetic cell culture platform for reproducible cell therapy development
Stembond Technologies is a Cambridge University spin-out developing a synthetic, mechanically tuned biomimetic substrate that replicates the physical properties of human tissue microenvironments. The platform delivers reproducible cell culture conditions, reducing phenotypic drift and improving consistency across…
Alternative protein research, education and academic collaboration network
Cambridge University Alt Protein Project is a student-led ecosystem organisation connecting researchers, students and entrepreneurs working on alternative proteins. It supports education and collaboration across cultivated meat, plant-based foods and fermentation through workshops, academic mapping and scientific…
Longer-lasting RNA medicines and immune-stealthed CAR-T research
Cambridge RNA Technologies develops experimental RNA platforms intended to extend the duration of therapeutic gene expression. Its research includes technologies for longer-lasting RNA medicines. In collaboration with Anglia Ruskin University, the company has investigated immune-stealth approaches for donor-derived…
Fragment-based drug discovery platform for oncology and CNS disorders
Astex Pharmaceuticals is a drug discovery and development company pioneering fragment-based drug discovery through its proprietary Pyramid platform, applied to oncology and central nervous system disorders. Astex maintains an internal pipeline alongside active collaborations with MSD targeting KRAS and p53. The…
Birthplace of molecular biology researching fundamental processes in human disease
The MRC Laboratory of Molecular Biology researches fundamental biological processes at the level of atoms, molecules, cells and organisms, applying this knowledge to major problems in human health and disease. The Laboratory pioneered techniques including DNA sequencing, protein structure determination and the…
CRISPR-engineered tumour-infiltrating lymphocyte therapy
Intima Bioscience is a clinical-stage biotechnology company developing CRISPR gene-edited tumour-infiltrating lymphocyte therapies for solid tumours. Its platform targets CISH, an intracellular immune checkpoint that suppresses T cell activity against tumours; CRISPR knockout of CISH in patient-derived TILs enhances…
Fragment-based drug discovery with a glioblastoma focus
IOTA Pharmaceuticals is a Cambridge drug discovery company specialising in fragment-based design, molecular screening and computational approaches to early-stage therapeutics. Its research combines transcriptomics, phenotypic assays and natural product screening to investigate candidate treatments. A major focus is…
AI-guided RNA therapies for chronic metabolic diseases
Elarna Bio is a biotechnology company developing long-acting RNA therapeutics for chronic metabolic diseases. It combines AI-driven discovery with RNA engineering to improve the duration of therapeutic activity. The platform focuses on challenges associated with liver-targeted RNA treatments and is intended for…
Pharma-university venture funding early-stage translational research
Apollo Therapeutics is a biopharma company advancing therapeutic programmes derived from research at partner universities including Cambridge, Imperial College London, UCL, King's College London, and the Institute of Cancer Research. Originally a joint venture between three universities and AstraZeneca, GSK, and…
University spatial transcriptomics and imaging platform for tissue research
The DRP Spatial Platform is a university core facility that supports spatial transcriptomics and imaging projects. It offers experimental design, histology and sample preparation, tissue imaging and laser capture microdissection, and spatial gene expression profiling, with support for data quality control and…
Targeted small-molecule drugs for brain and metastatic cancers
Sentinel Oncology is a biotechnology company developing targeted small-molecule drugs for difficult-to-treat cancers. Its medicinal chemistry programmes investigate DNA damage responses and cell division. Some candidates are designed to cross the blood-brain barrier, targeting primary brain tumours and cancers that…
Technology transfer and commercialisation office of the University of Cambridge
Cambridge Enterprise is the commercialisation arm of the University of Cambridge, supporting the translation of university research into commercial ventures. It manages intellectual property licensing, supports the formation and development of spinout companies, and provides consultancy services connecting university…
Antibodies, proteins and reagents for life science research
Abcam is a global supplier of biological research reagents and tools serving approximately 750,000 researchers across more than 130 countries. The company develops and distributes a broad catalogue of primary and secondary antibodies, immunoassay kits, proteins, peptides and cellular assay tools supporting drug…
Supramolecular encapsulation chemistry for controlled active delivery
Aqdot is a chemical technology company developing supramolecular systems for capturing, protecting and releasing active ingredients. Its encapsulation platform is commercially applied to odour removal and industrial formulations, while its research extends to RNA delivery systems for vaccines and cancer therapies. The…
Free-to-attend conferences and events for life science professionals
ELRIG (European Laboratory Research and Innovation Group) is a not-for-profit, volunteer-led organisation serving the UK and international life science and drug discovery communities. It delivers free-to-attend conferences, networking events, and webinars spanning drug discovery, cell and gene therapy, and laboratory…